Needle-Free Injector Gaining More Acceptances In Many Countries

Medical International Technology Inc. is pleased to announce the sale of 12 units
of the AGRO-JET MIT II P to "Jennie O", one of the largest Turkey farms in the USA. MIT, a
developer and manufacturer of patented low pressure needle free jet injectors for human and
animal inoculation, is also undergoing trials with Cargil (turkey breeders), Tyson Food (the pork
division) and Seaboard Foods (one of the largest pork producers in the USA).


MIT sold other units of AGRO-JET in the USA to Merial USA for vaccination of chicken, to Turner
Enterprises Inc. for vaccination of Bison and to Kraft food for lab testing.
Customers in other countries like Canada, New Zealand, China and Malaysia have purchased
AGRO-JET for the vaccination of Pork, Mink and cattle.


At the present time, the world's Animal industry (Poultry, Pork, Cattle etc.) commonly uses a
needle/syringe to vaccinate. The current method for vaccination requires that the needle be
changed after a few hundred birds in Poultry; between 20 and 35 in Pork and few Cattle's have
been injected. This method poses a major problem as cross contamination may occur and more
importantly, increases the risk of infecting the person vaccinating, with an accidental needlesticks
and Sharps Injuries.


"Medical International Technology Inc. is pleased to be able to continue providing a safer, low
pressure needle-free injection solution to the Global Animal industry," With the use of "MIT"
AGRO-JET, we can safely vaccinate all Animals and help prevent the spread of deadly disease to
Animals and Humans.


About Medical International Technology, Inc.


MIT CANADA, with offices in Montreal, is a
subsidiary of Denver, Colorado-based Medical International Technology, Inc. (MIT USA), which
specializes in the development, production, marketing and sale of needle-free injectors both for
humans and animals, for individual and mass vaccinations


The statements which are not historical facts contained in this press release are forward-looking
statements that involve certain risks and uncertainties, including but not limited to risks
associated with the uncertainty of future financial results, additional financing requirements,
development and acquisition of new product lines and services, government approval processes,
the impact of competitive products or pricing a technological changes, the effect of economic
conditions and other uncertainties, and the risk factors set forth from time to time in the
Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its
quarterly reports on Forms 10-QSB; and any reports on Form 8-K. Medical International
Technology Inc. takes no obligation to update or correct forward-looking statements.


mitcanada.ca

mitinvest.ca